Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2022 Jun:150:292-299.
doi: 10.1016/j.jpsychires.2022.02.034. Epub 2022 Mar 9.

Effects of an immersive psychosocial training program on depression and well-being: A randomized clinical trial

Affiliations
Randomized Controlled Trial

Effects of an immersive psychosocial training program on depression and well-being: A randomized clinical trial

Ariel B Ganz et al. J Psychiatr Res. 2022 Jun.

Erratum in

Abstract

Psychiatry stands to benefit from brief non-pharmacological treatments that effectively reduce depressive symptoms. To address this need, we conducted a single-blind randomized clinical trial assessing how a 6-day immersive psychosocial training program, followed by 10-min daily psychosocial exercises for 30 days, improves depressive symptoms. Forty-five adults were block-randomized by depression score to two arms: (a) the immersive psychosocial training program and 10-min daily exercise group (36 days total; total n = 23; depressed at baseline n = 14); or (b) a gratitude journaling control group (36 days total; total n = 22; depressed at baseline n = 13). The self-report PHQ-9 was used to assess depression levels in both groups at three time points: baseline, study week one, and study week six. Depression severity improved over time, with a significantly greater reduction in the psychosocial training program group (-82.7%) vs. the control group (-23%), p = 0.02 for baseline vs. week six. The effect size for this reduction in depression symptoms was large for the intervention group (d = -1.3; 95% CI, -2.07, -0.45; p < 0.001) and small for the control group (d = -0.3; 95% CI, -0.68, 0.03; p = 0.22). Seventy-nine percent (11/14) of depressed participants in the intervention condition were in remission (PHQ-9 ≤ 4) by week one and 100% (14/14) were in remission at week six. Secondary measures of anxiety, stress, loneliness, and well-being also improved by 15-80% in the intervention group (vs. 0-34% in the control group), ps < 0.05. Overall, this brief, immersive psychosocial training program rapidly and substantially improved depression levels and several related secondary outcomes, suggesting that immersive interventions may be useful for reducing depressive symptoms and enhancing well-being.

Keywords: Depression; Health; Intervention; Resilience; Stress; Well-being.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest

We have no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
CONSORT Flow Diagram describing phases of the randomized clinical trial.
Fig. 2.
Fig. 2.
Summary of changes in, and associations between, study outcomes. (A) Changes in depression severity over time for participants in the psychosocial training program (left) and control group (right). Points are colored by initial depression (green = initially depressed, PHQ-9 ≥5; blue = not initially depressed). (B) Effect sizes for the outcome measures when comparing the change in the training program group to the change in the control group from baseline to week six.

References

    1. Anatchkova MD, Bjorner JB, 2010. Health and role functioning: the use of focus groups in the development of an item bank. Qual. Life Res 19, 111–123. - PMC - PubMed
    1. Butler J, Kern ML, 2016. The PERMA-Profiler: a brief multidimensional measure of flourishing. Intnl. J. Wellbeing 6, 1–48.
    1. Cosci F, Chouinard G, 2020. Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychother. Psychosom 89, 283–306. - PubMed
    1. Davis AK, Barrett FS, May DG, Cosimano MP, Sepeda ND, Johnson MW, Finan PH, Griffiths RR, 2020. Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial. JAMA Psychiatr. 78, 481–489. - PMC - PubMed
    1. Dejesus RS, Vickers KS, Melin GJ, Williams MD, 2007. A system-based approach to depression management in primary care using the Patient Health Questionnaire-9. Mayo Clin. Proc 82, 1395–1402. - PubMed

Publication types